A. Sil

Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study

Jerome H. Kim, J. Yang, J. Lynch, 2020, EClinicalMedicine.

A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh.

J. Ferdous, F. Qadri, J. Clemens, 2021, Vaccine.

Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants

A. Dubey, S. Bavdekar, Madhu Gupta, 2015, Human vaccines & immunotherapeutics.

Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose

Jerome H. Kim, J. Yang, J. Y. Park, 2022, NPJ vaccines.

Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants.

A. Dubey, S. Bavdekar, Madhu Gupta, 2017, Vaccine.

A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years of Age

Min Soo Kim, Jerome H. Kim, J. Yang, 2022, The Lancet regional health. Western Pacific.

A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2–11 years: a phase II preliminary report

J. Yang, S. Hadinegoro, H. I. Satari, 2020, BMC Pediatrics.

One-month follow up of a randomized clinical trial-phase II study in 6-<24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine.

J. Yang, S. Hadinegoro, H. I. Satari, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose

J. Yang, J. Y. Park, B. T. Tadesse, 2022, npj Vaccines.

Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report

Jerome H. Kim, J. Yang, J. Lynch, 2020, Vaccine.